Atractylenolide iii predisposes mir-195-5p/fgfr1 signaling axis to exert tumor-suppressive functions in liver cancer

HIGHLIGHTS

• who: Posted Date August and collaborators from the Xiangya Hospital Central South University have published the research: Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer, in the Journal: (JOURNAL)
• what: The authors aimed to investigate whether ATL induced growth inhibition and apoptosis in HCC cells by targeting miR-195-5p/FGFR1 signaling pathway. The authors focused on miR-195-5p in further study.
• how: To study the anti-tumor activity of ATL cell apoptosis was tested in ATL-treated HepG2 and SMMC7721 cells which . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.